| Heading: |
Parkinson's Disease: Greater Manchester |
| Question ID: |
1804958 |
| UIN: |
54002 |
| House: |
Commons |
| Date tabled: |
2025-05-21 |
| Asking Member ID: |
4811 |
| Asking Member display name: |
Navendu Mishra
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Navendu Mishra
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the availability of Produodopa treatment for people with Parkinson’s in (a) Stockport and (b) Greater Manchester. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is not aware of a supply issue affecting Produodopa.The Department monitors and manages medicine supply at a national level so that stocks remain available to meet regional and local demand. Information on stock levels within Stockport and ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |